08/11/2016 - 06:24

MGC Pharma on verge of EU approval to sell cannabis cosmetics

08/11/2016 - 06:24

Bookmark

Save articles for future reference.

ASX-listed MGC Pharma is a step closer to breaking into the lucrative European skincare market, with the medical cannabis company commencing official EU registration for its cannabis-based cosmetics used to treat conditions such as acne, psoriasis and seborrhoea.

Subscribe today for award-winning, unbiased and trusted journalism

Subscription Options